Address
Delphi Ventures Inc
3000 Sand Hill Toad
1-135
Menlo Park, CA 09650
United States
Phone
Website
Recent investment activity
KANDO id: 27619
Corporate information
Founders
Official name
Delphi Ventures Inc
Registration country
Company type
Venture capital firm with a focus on early stage investing in medical devices and biotechnologyFunds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Delphi Ventures VIII LP | Venture | 2008 | USD | 300,000,000 |
| Delphi Ventures VII LP | Venture | 2005 | USD | 250,000,000 |
| Delphi Ventures VI LP | Venture | 2002 | USD | 150,000,000 |
| Delphi Ventures V LP | Venture | 2000 | USD | 147,000,000 |
| Delphi Ventures IV LP | Venture | 1998 | USD | 125,000,000 |
| Delphi Ventures III LP | Venture | 1995 | USD | 80,000,000 |
| Delphi Ventures II LP | Venture | 1992 | USD | 49,000,000 |
| Delphi Ventures LP | Venture | 1988 | USD | 43,000,000 |
Funding rounds
Actual initial investment stage
N/A (5)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 100| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Accordant Health Services Inc | N/A | ||||
|
|
Alder Biopharmaceuticals Inc | Developer of antibody therapeutics. | N/A | |||
|
|
Applied Molecular Evolution Inc | N/A | ||||
|
|
Aragon Surgical Inc | Unique RF based medical devices to facilitate speed and safety for general surgery and gynecological procedures | Series B | |||
|
|
ArKal Medical Inc | Developing a simple, needle-free minimally invasive continuous glucose monitoring(CGM) system that is highly accurate and near painless | N/A | |||
|
|
Astute Medical Inc | Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers | Series C | |||
|
|
Astute Medical Inc | Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers | Series B | |||
|
|
Axya Medical Inc | N/A | ||||
|
|
BaroSense Inc | A medical device company | Series D | |||
|
|
BMJ Medical Management Inc | N/A | ||||
|
|
Cameron Health Inc | A medical device company that has developed a totally subcutaneous implantable defibrillator – the S-ICD System. | Series E | |||
|
|
CaraVita Senior Care Management LLC (CVSC LLC), (CaraVita) | Senior care management services company focused on independent living, assisted living, skilled nursing, day care, and private home care. | N/A | |||
|
|
Cardiac Pathways Corp | N/A | ||||
|
|
Cardiometrics Inc | Intravascular medical devices for coronary artery disease | N/A | |||
|
|
ChemTrak Inc | N/A | ||||
|
|
CollaGenex Pharmaceuticals Inc | N/A | ||||
|
|
CV Therapeutics Inc | Subsidiary of Gilead Sciences Inc | N/A | |||
|
|
Cygnus Inc | N/A | ||||
|
|
Cytel Inc | A Science and Technology Company | N/A | |||
|
|
EBR Systems Inc | A venture-backed clinical stage company founded to develop implantable systems for wireless tissue stimulation | Series C | |||
|
|
ELENZA Inc | Develops electronic AutoFocal intraocular lens | Series B | |||
|
|
Evalve Inc | Series D | ||||
|
|
Exogen Inc | Engaged in the design, development, manufacture, and marketing of medical devices for the non-invasive treatment of musculoskeletal injury and disease | N/A | |||
|
|
Focal Interventional Therapeutics Inc | N/A | ||||
|
|
Gynecare Inc | N/A |